NEUROACTIVE STEROID FOR THE TREATMENT OF HUNTINGTON'S DISEASE

Provided herein are methods for improving working memory and/or executive function in a subject suffering from Huntington's Disease, comprising administering to the subject SAGE-718, an investigational positive allosteric modulator of the NMDA receptor. La présente invention concerne des méthod...

Full description

Saved in:
Bibliographic Details
Main Authors QUIRK, Michael C, KOENIG, Aaron Michael
Format Patent
LanguageEnglish
French
Published 22.06.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided herein are methods for improving working memory and/or executive function in a subject suffering from Huntington's Disease, comprising administering to the subject SAGE-718, an investigational positive allosteric modulator of the NMDA receptor. La présente invention concerne des méthodes destinées à améliorer la mémoire de travail et/ou la fonction exécutive chez un sujet souffrant de la maladie de Huntington, comprenant l'administration au sujet de SAGE-718, un modulateur allostérique positif d'investigation du récepteur NMDA.
Bibliography:Application Number: WO2022US52596